&Partners’s Terns Pharmaceuticals TERN Stock Holding History

&Partners’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,428	Closed	-$233K	–	2564
2026 Q1	$233K	Buy	+4,428	New	+$182K	﹤0.01%	2156

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

&Partners's TERN Position: Q2 2026 in Review

&Partners sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 4,428 shares — an estimated $233K sold.

&Partners first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $233K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

&Partners reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
&Partners sold 4,428 Terns Pharmaceuticals shares in Q2 2026, an estimated $233K.
&Partners first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
&Partners's Terns Pharmaceuticals position peaked at $233K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.